By contrast, treatment of high-risk diabetic patients with GLP-1R agonists such as lixisenatide and exenatide, which are based on the structure of nonhuman exendin 4, has not resulted in consistent reductions in MACEs (17, 18)
Making the right decision for you Here's the bottom line: the decision about semaglutide during breastfeeding isn't black and white
We understand that everyones journey is unique
Mutations in these genes not only cause severe obesity but also frequently lead to a broad spectrum of neurological phenotypes, including intellectual disability, developmental delay, and behavioral abnormalities (e.g., autism-like features), highlighting the foundational role of hypothalamic development in energy homeostasis [12,14]
Firstly, Tanzeum is not recommended as a first-line treatment for patients inadequately controlled with diet and exercise.49 Secondly, its safety and efficacy remain unclear in patients with a history of pancreatitis as it has not been studied in this group.106 Additionally, Tanzeum is not suitable for treating type 1 diabetes or diabetic ketoacidosis, related to its pharmacological action and target disease
Also, while GI side effects are common with semaglutide, its still important to report these to your prescribing doctor